AI in Action E138: Carsten Ullrich, Director of AI at Centogene
AI in Action, Podcast | October 23 2020 | Mark Kelly
Welcome to episode 138 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.
Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.
Today’s guest is Carsten Ullrich, Director of AI at Centogene in Berlin. Centogene are one of the worldwide leaders in the field of early genetic diagnostics for rare hereditary diseases. A data repository of genetic data from over 115 countries gives them unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications. They focus exclusively on providing the highest quality, patient-centred service and outstanding short turn-around times for analysis.
Centogene believes their medical expertise is based on cutting-edge technologies including whole exome/genome sequencing, innovative biomarkers and continued R&D. Their mutation database is the world’s largest for rare genetic diseases and is pivotal to our high-quality diagnostic reporting and comprehensive medical interpretation. They are a key partner for many high-profile pharmaceutical companies who are active in orphan drug development.
In the show, Carsten will discuss:
His 20 years of experience working in AI
How Centogene are applying AI in rare diseases
Challenges they need to overcome, such as data quality
Improving diagnostics and leveraging this for new discoveries
What makes Centogene a great place to work
Their work with COVID-19 Testing
The possibility of AI with Superhuman capabilities
To find out more about Carsten and his work at Centogene, check out the website www.centogene.com or follow them on Twitter @Centogene. You can also follow Carsten on Twitter @ullrich or connect with him on Linkedin.
What did you make of Carsten’s podcast? Where do you see the future of Artificial Intelligence within Healthcare heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.
If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.
Subscribe to The Alldus Podcast:
Welcome to episode 138 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.
Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.
Today’s guest is Carsten Ullrich, Director of AI at Centogene in Berlin. Centogene are one of the worldwide leaders in the field of early genetic diagnostics for rare hereditary diseases. A data repository of genetic data from over 115 countries gives them unique access to epidemiological, clinical and genetic information on hereditary disorders, including oncogenetic indications. They focus exclusively on providing the highest quality, patient-centred service and outstanding short turn-around times for analysis.
Centogene believes their medical expertise is based on cutting-edge technologies including whole exome/genome sequencing, innovative biomarkers and continued R&D. Their mutation database is the world’s largest for rare genetic diseases and is pivotal to our high-quality diagnostic reporting and comprehensive medical interpretation. They are a key partner for many high-profile pharmaceutical companies who are active in orphan drug development.
In the show, Carsten will discuss:
His 20 years of experience working in AI
How Centogene are applying AI in rare diseases
Challenges they need to overcome, such as data quality
Improving diagnostics and leveraging this for new discoveries
What makes Centogene a great place to work
Their work with COVID-19 Testing
The possibility of AI with Superhuman capabilities
To find out more about Carsten and his work at Centogene, check out the website www.centogene.com or follow them on Twitter @Centogene. You can also follow Carsten on Twitter @ullrich or connect with him on Linkedin.
What did you make of Carsten’s podcast? Where do you see the future of Artificial Intelligence within Healthcare heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.
If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.
Subscribe to The Alldus Podcast:
share
related podcasts
ServiceNow Series E198: David McInnes, ServiceNow Engagement Manager & Andrew Ortiz, ServiceNow Practice Director at AdvizeX
Welcome to episode 198 in our ServiceNow series of the Alldus podcast, the show where we highlight the brightest talent and technical leadership within the ServiceNow ecosystem. Powered by Alldus International, our goal is to share with you the insights of leaders in the field to showcase the excellent work that is being done within…
Women in ServiceNow Series E08: Lise Fremo Furre, Partner at KPMG Norway
Welcome to the episode eight in our Women in ServiceNow series Alldus podcast, a brand new series dedicated to showcasing the incredible women leading the way in the ServiceNow ecosystem. Powered by Alldus International, host Ailsa Cassie brings you inspiring conversations with trailblazing women who are driving innovation, breaking barriers, and shaping the future of…
Women in ServiceNow Series E07: Reija Jokinen, Senior Advisor at Sofigate
Welcome to the episode seven in our Women in ServiceNow series Alldus podcast, a brand new series dedicated to showcasing the incredible women leading the way in the ServiceNow ecosystem. Powered by Alldus International, host Ailsa Cassie brings you inspiring conversations with trailblazing women who are driving innovation, breaking barriers, and shaping the future of…